Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Play a Major Role in CD4+ T-Cell Impairment During Sepsis.

The Journal of Infectious Diseases
Benjamin J GaboritKarim Asehnoune

Abstract

Sepsis causes inflammation-induced immunosuppression with lymphopenia and alterations of CD4+ T-cell functions that renders the host prone to secondary infections. Whether and how regulatory T cells (Treg) are involved in this postseptic immunosuppression is unknown. We observed in vivo that early activation of Treg during Staphylococcus aureus sepsis induces CD4+ T-cell impairment and increases susceptibility to secondary pneumonia. The tumor necrosis factor receptor 2 positive (TNFR2pos) Treg subset endorsed the majority of effector immunosuppressive functions, and TNRF2 was particularly associated with activation of genes involved in cell cycle and replication in Treg, probably explaining their maintenance. Blocking or deleting TNFR2 during sepsis decreased the susceptibility to secondary infection. In humans, our data paralleled those in mice; the expression of CTLA-4 was dramatically increased in TNFR2pos Treg after culture in vitro with S. aureus. Our findings describe in vivo mechanisms underlying sepsis-induced immunosuppression and identify TNFR2pos Treg as targets for therapeutic intervention.

References

Jan 28, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Matthew J Delano, Lyle L Moldawer
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Steven J SchwulstRichard S Hotchkiss
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manuela RossolUlf Wagner
Oct 5, 2007·Journal of Leukocyte Biology·Fabienne VenetAlfred Ayala
Jan 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ying WangMarie Malissen
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ChenJoost J Oppenheim
Jun 25, 2009·European Journal of Immunology·Johanna Dayer SchneiderChristoph Mueller
Dec 22, 2011·JAMA : the Journal of the American Medical Association·Jonathan S BoomerRichard S Hotchkiss
Dec 12, 2012·Trends in Immunology·Erika CretneyStephen L Nutt
Feb 23, 2013·The Lancet Infectious Diseases·Richard S HotchkissDidier Payen
Nov 16, 2013·Nature Reviews. Immunology·Richard S HotchkissDidier Payen
Jul 23, 2014·Shock·Anne M DrewryRichard S Hotchkiss
Sep 30, 2014·Nature Immunology·Andrew G LevineAlexander Y Rudensky
Oct 4, 2015·Current Opinion in Immunology·Allyson SpenceQizhi Tang
Jan 5, 2016·The Journal of Clinical Investigation·Matthew J Delano, Peter A Ward
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Manu Shankar-HariUNKNOWN Sepsis Definitions Task Force
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Lonneke A van VughtUNKNOWN MARS Consortium
Jul 31, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jérôme BitonNatacha Bessis
Aug 11, 2017·International Journal of Molecular Sciences·Amanda M PughVanessa Nomellini
Oct 25, 2017·Current Opinion in Immunology·Yohko Kitagawa, Shimon Sakaguchi
Mar 30, 2018·Frontiers in Immunology·Benoît L SalomonJosé L Cohen
Jun 20, 2018·Intensive Care Medicine·Andrew Conway MorrisTimothy S Walsh
Mar 21, 2020·Critical Care : the Official Journal of the Critical Care Forum·Guus P LeijteFabienne Venet

❮ Previous
Next ❯

Citations

Oct 1, 2020·International Journal of Molecular Sciences·Daniel M MrochenSilva Holtfreter

❮ Previous
Next ❯

Related Concepts

Related Feeds